Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
What upstairs market StepStone Group STEP Touches High 20260427 PRLD shares surge 6 despite Prelude earnings miss investors focus on pipeline catalysts and biotech outlook Fox FOXF delivers massive earnings beat with 115 EPS surprise shares rise 2 on revenue growth What makes First FGBI a stronger buy than it appears Touches High 20260508 Investors Shift Focus to SmallCap AI Tech Stocks for Potential Growth Opportunities Futures Rise as USIran Talks Signal Potential Deescalation HighYield Savings Rates Reach Up to 41 APY as of May 24 2026 SP 500 Rises as Tech Surge Offsets Energy and Consumer Weakness Star Bulk Carriers Files Form 6K with SEC Amid Routine Disclosure Cycle Workday WDAY Captures Attention as Potential AI Growth Driver FINV Q1 2026 Earnings EPS of 1764126 Drives Stock Surge Despite Missing Revenue Context Pathward Financial CASH Q1 2026 Earnings Earnings Miss on Weaker Net Interest Income Stock Edges Up HNNA Q1 2026 Earnings Asset Manager Posts 024 EPS as Stock Climbs Nearly 2 CNXN Q1 2026 Earnings EPS Surges Past Estimates with 2478 Surprise NTRSO Q1 2026 Earnings Northern Trust Beats EPS Estimates by 1435 Shares Dip Slightly OLLI Q1 2026 Earnings EPS Misses Estimates Amid Challenging Retail Environment Virco Manufacturing VIRC Holds Steady Near Support as Traders Await Catalyst Adamas Trust Senior Notes ADAMO Hold Steady Near 2528 Amid Low Volatility Hub Cyber Security HUBC Faces Continued Pressure Testing Key Support Levels Fulton Financial Preferred Shares FULTP Edge Lower Amid Modest Pullback Tenaya Therapeutics TNYA Edges Higher Biotech Stock Tests Key Resistance at 084 How Aspen Ins AHLF balances short term and long term focus The growth story Beazer Homes BZH is not telling investors Edges Up 20260506 Why Neumora Therapeutics NMRA might be the steady performer you need Technical Strength 20260506 How Landstar System LSTR performance reflects its true potential Slight Uptick 20260508 HURA TuHURA Biosciences Q4 2025 EPS trails estimates by 282 percent shares slip 141 percent in todays trading How ANI Pharma ANIP management quality drives results Bearish Sentiment 20260508